MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: Gastroenterology
Gastroenterology

Rapid Skeletal Muscle Loss in Cirrhosis: Predictors, Outcomes, and Implications for Clinical Management

MedXY Editorial TeamAug 4, 2026
cirrhosisSarcopeniaMELD-Namuscle loss

Highlight

  • Median annual skeletal muscle loss in patients with cirrhosis awaiting liver transplantation is approximately 1.6%.

  • Rapid muscle loss (RML), defined as the worst quartile of muscle loss (< -7.4% per year), predicts significantly higher waitlist mortality independent of MELD-Na score.

  • Ascites and higher MELD-Na scores independently associate with increased risk of RML.

  • Understanding the rate of muscle loss and its predictors informs prognostication and potential interventions targeting sarcopenia in cirrhosis.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Inpatient Mobility Scores Predict Liver Transplant Outcomes and Mortality in Hospitalized Cirrhosis Patients

GastroenterologyNov 7, 2026

Intravenous Albumin Post-Outpatient Paracentesis Lowers AKI Hospitalization Risk in Cirrhosis: Insights from a National Cohort Study

GastroenterologyNov 7, 2026

Elafibranor as an Effective Second-Line Treatment to Normalize Alkaline Phosphatase in Primary Biliary Cholangitis with Incomplete Response to Ursodeoxycholic Acid: Synthesizing Evidence from the Phase III ELSPIRE Trial and Related Studies

GastroenterologyNov 13, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story